Subscribe to Newsletter

Advanced Medicine

Manufacture Advanced Medicine

The Next Decade of Cell and Gene Therapies

| 5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems; we ask experts about the future of advanced medicine.
Discovery & Development Drug Discovery

Rewards in the Real World: Sitting Down With Igor Fisch

| 4 min read

Discussing the development of trends, treatments, and talent in gene therapy with NewBiologix CEO Igor Fisch.
Manufacture Advanced Medicine

Cell Therapy: Getting GMP Right

| Stephanie Vine | 2 min read

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.
Manufacture Advanced Medicine

Coming Soon: the Power List

| Rob Coker | 2 min read

The 2025 Power List will be available soon!
Business & Regulation Business Practice

The Trump Effect on Cell and Gene: Science versus Shockwaves

| 9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track
Business & Regulation Standards & Regulation

Peter Marks Resigns from FDA

| Stephanie Vine | 3 min read

Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.
Manufacture Advanced Medicine

Building a Resilient CGT Workforce

| Daniel Palmacci | 3 min read

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.
Business & Regulation Advanced Medicine

We Need to Talk About CRISPR

| 4 min read

Neal Baer, editor of a collection of essays on CRISPR, says we must not overlook the dark side of the technology.
Manufacture Advanced Medicine

Partnership Cuts Cost of CAR T Manufacturing

| 4 min read

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that?
Discovery & Development Drug Discovery

Rethinking Osteoarthritis With Extracellular Vesicles

| 4 min read

Why researchers are excited about the potential of extracellular vesicles from umbilical cord-derived stem cells.

Latest White Papers

Single ingredient optimization supports the expansion of pluripotent stem cells

| Contributed by Novo Nordisk

How to Improve the Capturing of Antibody Fragments

| Contributed by Tosoh

Accelerate innovation and manufacturing to better serve patients

| Contributed by GenScript Probio

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

February Issue of The Medicine Maker